Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG

Mertlíková-Kaiserová, H., Rumlová, M., Tloušťová, E., Procházková, E., Holý, A., Votruba, I. Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG. Biochemical Pharmacology. 2011, 82(2), 131-138. ISSN 0006-2952. E-ISSN 1873-2968. Dostupné z: doi: 10.1016/j.bcp.2011.04.002